NCT05172674

Brief Summary

Objectives: to identify which type of placental and umbilical cord abnormalities are more common in IVF singleton pregnancies; to investigate if heterologous fertilization is an additional risk factor for the development of these abnormalities. Methods: this was a multicenter prospective cohort study study involving two tertiary centres (S. Orsola Hospital, University of Bologna and Institute for Women's Health, University College of London). Patients with a singleton pregnancy conceived with IVF were consecutively recruited between May 2019 to January 2021. Each case was matched with a control presenting with a spontaneous pregnancy during the same period of time. All patients underwent similar antenatal care, which included ultrasound examinations at 11-14, 19-22 and 33-35 weeks. Ultrasound findings of placental and/or umbilical cord abnormalities were recorded in the two groups and confirmed after birth. The incidence of placental/cord findings in the study group was assessed using the chi-squared test or Fisher's exact test, where appropriate. Post-hoc pairwise comparisons were performed with the Fisher's exact test, using the Simes' method for false discovery rate control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
587

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 29, 2021

Completed
Last Updated

February 14, 2022

Status Verified

January 1, 2022

Enrollment Period

1.9 years

First QC Date

December 13, 2021

Last Update Submit

January 31, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • type of placental and umbilical cord abnormalities

    to identify which type of placental and umbilical cord abnormalities are more common in IVF singleton pregnancies

    8 months

  • heterologous fertilization

    to investigate if heterologous fertilization is an additional risk factor for the development of these abnormalities

    8 months

Study Arms (2)

spontaneous pregnancies

Diagnostic Test: ultrasound according routine antenatal care

pregnancies arising through IVF (homologus + hetereologus)

Diagnostic Test: ultrasound according routine antenatal care

Interventions

ultrasound examinations at 11-14, 19-22 and 33-35 weeks

pregnancies arising through IVF (homologus + hetereologus)spontaneous pregnancies

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients with a singleton pregnancy conceived with IVF were consecutively recruited between 1st of May 2019 to 31st March 2021. Each case was matched with a control presenting with a SC during the same period of time. All patients had antenatal care using a similar clinical protocol, which included at 11-14 weeks (nuchal thickness screening scan), 19-22 weeks (detailed fetal anatomy scan) and 33-35 weeks (growth scan).

You may qualify if:

  • singleton pregnancies
  • spontaneous pregnancies or pregnancies conceived with IVF

You may not qualify if:

  • multiple pregnancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, 40138, Italy

Location

MeSH Terms

Conditions

Placenta Diseases

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2021

First Posted

December 29, 2021

Study Start

May 1, 2019

Primary Completion

March 31, 2021

Study Completion

March 31, 2021

Last Updated

February 14, 2022

Record last verified: 2022-01

Locations